ArticlePLoS pathogens2022

Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis.

Haider S Manzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.